Funding event
The round itself, as filedInferred stageSeries B
Sold of offered$35.1M of $80.1M
Filed2026-10-05
Days since filing13
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-09-18
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- James M. AlecxihExecutive Officer · Director
- Robert LaridExecutive Officer
- Tyler StowaterDirector
- Fernando PachecoDirector
- Amy KobeDirector
- Shahryar OveissiDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-17UndersubscribedNot flagged43.8% sold1 month since first sale
Prior raiseNot flaggedRaised 636% of its prior round, 18 months on$5.5M prior raise, filed 2025-04-03
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-10-060
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-18Estuary BioSeries B · $40.7M of $104M · Menlo Park, CAQuietNorth Elam Ambulatory Surgery Center, LLCSeed · $1.8M of $2.7M · Greensboro, NCQuiet
70 rounds in Health & bio in the 28 days to 2026-10-17, against 66 in the 28 days before.